|4Jul 21, 7:23 PM ET

Nielsen Jack 4

4 · Aligos Therapeutics, Inc. · Filed Jul 21, 2023

Insider Transaction Report

Form 4
Period: 2023-07-20
Nielsen Jack
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-20+20,00020,000 total
    Exercise: $1.00Exp: 2033-07-20Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2024 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary